| Richard G Kavanagh, MB,BCH,BAO | |
|
55 Fruit St, Massachusetts General Hospital, Boston, MA 02114-2621 | |
| (617) 643-2009 | |
| Not Available |
| Full Name | Richard G Kavanagh |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 55 Fruit St, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053818708 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 274774 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Richard G Kavanagh, MB,BCH,BAO 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114-2621 Ph: (617) 643-2009 | Richard G Kavanagh, MB,BCH,BAO 55 Fruit St, Massachusetts General Hospital, Boston, MA 02114-2621 Ph: (617) 643-2009 |
News Archive
A team of researchers has found that the microflora of bacteria within the gut of humans could be a contributor to the development of pulmonary arterial hypertension (PAH). The study titled, "Altered Gut Microbiome Profile in Patients With Pulmonary Arterial Hypertension," in the latest issue of the American Heart Association's journal Hypertension.
After menopause, non-Hispanic Black women are more likely to experience weight gain than non-Hispanic white women, researchers at the Rush Institute for Healthy Aging have found. The results of their study were published March 1 in the medical journal PLOS ONE.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States Food & Drug Administration has extended the Prescription Drug User Fee Act Priority Review action date for the ulcerative colitis indication of Takeda's investigational biologic, vedolizumab.
X-ray beams could kick start genes into fighting cancer as an exciting new way of targeting therapy against the disease, according to new research in the Journal of Gene Medicine.
Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant chemotherapy shows no statistically significant difference in 3-year disease-free survival (DFS), according to data presented at ESMO 2020.
› Verified 6 days ago
Jennifer Michelle Thomas, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Department Of Radiology, Boston, MA 02115 Phone: 617-732-6248 | |
Dr. Meghavi Mashar, MB BCHIR Radiology Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 | |
Rafeeque A Bhadelia, M.D Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 Brookline Ave, Bidmc Wcc90, Boston, MA 02215 Phone: 617-754-2058 Fax: 617-754-2004 | |
Dr. Srinivasan Mukundan Jr., M.D. Radiology Medicare: Medicare Enrolled Practice Location: 75 Francis St, Brigham And Women's Hospital, Boston, MA 02115 Phone: 617-732-7260 | |
Raymond W Liu, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Grb 293, Boston, MA 02114 Phone: 917-923-2079 | |
Dr. Hillary R. Kelly, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Massachusetts General Hospital, 55 Fruit Street, Grb-273a, Boston, MA 02114 Phone: 617-726-8320 Fax: 617-724-3338 | |
Dr. Tina Young Poussaint, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6450 |